Medical Laboratory Scientist Sample Clauses

Medical Laboratory Scientist. A medical Laboratory Scientist shall receive an annual rate of salary approved by the employer for the position held. Step 5th September 2015 $ 20th January 2016 $ 18 95,680 97,115 17 92,334 93,719 16 88,989 90,324 15 85,643 86,928 14 82,298 83,532 13 78,953 80,137 12 75,608 76,742 11 72,596 73,685 10 69,584 70,628 9 66,574 67,573 8 63,563 64,516 7 61,612 62,536 6 59,661 60,556 5 57,710 58,576 4 55,757 56,593 3 53,806 54,613 2 51,854 52,632 1 46,939 47,643
Sample 1Sample 2See All (8)
AutoNDA by SimpleDocs
Medical Laboratory Scientist. The employer may credit previous service for salary purposes only for connected service (as defined below) for medical laboratory technologists as follows: Service in private laboratories Full credit Service in hospital laboratories Full credit Service in university laboratories Full credit
Sample 1Sample 2Sample 3See All (4)
Medical Laboratory Scientist. A Medical Laboratory Scientist shall receive an annual rate of salary approved by the employer for the position held. Step Pay Period 6/9/17 – 5/9/18 Pay Period 6/9/18 – 1/3/20 Per annum Hourly rate Per annum Hourly rate 18 97602 46.7890 99554 47.7247 17 94191 45.1538 96075 46.0569 16 90778 43.5177 92594 44.3881 15 87365 41.8816 89112 42.7192 14 83952 40.2455 85631 41.0504 13 80539 38.6094 82150 39.3816 12 77127 36.9738 78670 37.7133 11 74056 35.5015 75537 36.2115 10 70983 34.0282 72402 34.7088 9 67913 32.5564 69271 33.2075 8 64841 31.0841 66138 31.7058 7 62850 30.1296 64107 30.7322 6 60859 29.1751 62077 29.7586 5 58869 28.2211 60047 28.7856 4 56878 27.2667 58016 27.8120 3 54887 26.3122 55985 26.8384 2 52898 25.3587 53956 25.8659 1 47883 22.9544 48841 23.4135
Sample 1
Medical Laboratory Scientist. A Medical Laboratory Scientist shall receive an annual rate of salary approved by the employer for the position held. Employees who meet the appropriate progression criteria below shall progress to the appropriate step as follows. Applications for consideration for progression outside of this set progression criteria can be made by the employee at any time.
Sample 1Sample 2
Medical Laboratory Scientist. A Medical Laboratory Scientist shall receive an annual rate of salary approved by the employer for the position held. Scientists 1 December 2020 1 December 2021 1 December 2022 Step Per Annum Hourly rate Per Annum Hourly rate Per Annum Hourly rate 1a Graded Position 103,576 49.6528 105,647 50.6459 107,760 51.6588 1b Graded Position 99,956 47.9176 101,955 48.8760 103,994 49.8535 1c Graded Position 96,334 46.1814 98,261 47.1050 100,226 48.0471 2a Graded Position 92,712 44.4451 94,567 45.3340 96,458 46.2407 2b Graded Position 89,091 42.7089 90,872 43.5630 92,690 44.4343 2c Graded Position 85,469 40.9726 87,178 41.7921 88,922 42.6279 3a Graded Position 81,848 39.2369 83,485 40.0216 85,155 40.8220 3b Graded Position 78,589 37.6745 80,161 38.4279 81,764 39.1965 Scientist step 1 75,000 35.9540 77,000 36.9128 80,000 38.3509 Scientist step 2 72,069 34.5491 73,511 35.2401 74,981 35.9449 Scientist step 3 68,810 32.9867 70,186 33.6464 71,590 34.3193 Scientist step 4 66,697 31.9738 68,031 32.6133 69,392 33.2655 Scientist step 5 65,849 31.5671 67,166 32.1984 68,509 32.8424 Scientist step 6 63,396 30.3914 64,664 30.9992 65,958 31.6192 Scientist step 7 58,247 27.9227 59,412 28.4812 60,600 29.0508 Scientist step 8 56,136 26.9108 57,259 27.4491 58,404 27.9980 Scientist step 9 53,101 25.4561 54,163 25.9652 55,247 26.4845
Sample 1
Medical Laboratory Scientist. A Medical Laboratory Scientist shall receive an annual rate of salary approved by the employer for the position held. Step per annum from 29/02/16 17 $ 95,775 16 $ 92,399 15 $ 89,077 14 $ 85,728 13 $ 82,379 12 $ 79,031 HOD minimum 11 $ 75,683 10 $ 72,668 Technician Specialist / 2IC minimum 9 $ 69,655 Senior Scientist 8 $ 66,641 7 $ 63,627 6 $ 61,673 5 $ 59,719 4 $ 57,767 3 $ 53,859 2 $ 51,906 1 $ 46,985 Trainee Employees who meet the appropriate progression criteria below shall progress to the appropriate step as follows. Applications for consideration for progression outside of this set progression criteria can be made by the employee at any time.
Sample 1
Medical Laboratory Scientist. 1 Feb 2020 1 Feb 2021 1 Feb 2022 1 Feb 2023 Step Hourly rate Per Annum Hourly Rate Per Annum Hourly Rate Per Annum Hourly Rate Per Annum S18 49.156 102,540 50.140 104,591 51.142 106,683 52.165 108,817 S17 47.439 98,957 48.387 100,936 49.355 102,955 50.342 105,014 S16 45.720 95,371 46.634 97,279 47.567 99,224 48.518 101,209 S15 44.001 91,786 44.881 93,621 45.778 95,494 46.694 97,404 S14 42.282 88,200 43.128 89,964 43.990 91,763 44.870 93,599 S13 40.563 84,615 41.374 86,307 42.202 88,033 43.046 89,794 S12 38.845 81,030 39.719 82,853 40.612 84,717 41.526 86,624 S11 37.298 77,803 38.230 79,748 39.186 81,742 40.166 83,786 S10 35.750 74,575 36.823 76,812 37.927 79,116 39.065 81,490 S9 34.204 71,349 35.534 74,124 36.917 77,008 38.353 80,003 S8 32.657 68,122 33.722 70,343 34.821 72,636 35.956 75,004 S7 31.654 66,031 32.430 67,648 33.224 69,306 34.038 71,004 S6 30.651 63,939 31.289 65,269 31.940 66,626 32.604 68,012 S5 29.649 61,848 30.301 63,209 30.968 64,599 31.649 66,021 S4 28.646 59,756 29.311 61,143 29.991 62,561 30.687 64,013 S3 27.644 57,664 28.321 59,077 29.015 60,525 29.726 62,007 S2 26.642 55,575 27.332 57,014 28.040 58,491 28.766 60,006 S1 24.116 50,306 24.695 51,513 25.287 52,749 25.894 54,106 Automatic salary increments shall take effect from the anniversary date of the employee’s employment and the employee must have worked for a minimum of six months to qualify for any incremental increase.
Sample 1
AutoNDA by SimpleDocs

Related to Medical Laboratory Scientist

  • Laboratory Services Covered Services include prescribed diagnostic clinical and anatomic pathological laboratory services and materials when authorized by a Member's PCP and HPN’s Managed Care Program.

  • HEALTH PROGRAM 3701 Health examinations required by the Employer shall be provided by the Employer and shall be at the expense of the Employer. 3702 Time off without loss of regular pay shall be allowed at a time determined by the Employer for such medical examinations and laboratory tests, provided that these are performed on the Employer’s premises, or at a facility designated by the Employer. 3703 With the approval of the Employer, a nurse may choose to be examined by a physician of her/his own choice, at her/his own expense, as long as the Employer receives a statement as to the fitness of the nurse from the physician. 3704 Time off for medical and dental examinations and/or treatments may be granted and such time off, including necessary travel time, shall be chargeable against accumulated income protection benefits.

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

  • Technology Research Analyst Job# 1810 General Characteristics Maintains a strong understanding of the enterprise’s IT systems and architectures. Assists in the analysis of the requirements for the enterprise and applying emerging technologies to support long-term business objectives. Responsible for researching, collecting, and disseminating information on emerging technologies and key learnings throughout the enterprise. Researches and recommends changes to foundation architecture. Supports research projects to identify and evaluate emerging technologies. Interfaces with users and staff to evaluate possible implementation of the new technology in the enterprise, consistent with the goal of improving existing systems and technologies and in meeting the needs of the business. Analyzes and researches process of deployment and assists in this process.

  • Laboratory Testing All laboratories selected by UPS Freight for analyzing Controlled Substances Testing will be HHS certified.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Professional Development Program (a) The parties agree to continue a Professional Development Program for the maintenance and development of the faculty members' professional competence and effectiveness. It is agreed that maintenance of currency of subject knowledge, the improvement of performance of faculty duties, and the maintenance and improvement of professional competence, including instructional skills, are the primary professional development activities of faculty members.

  • Manufacturing Technology Transfer With respect to each Technology Transfer Product, upon AbbVie’s written request after the Inclusion Date for the Included Target to which such Technology Transfer Product is Directed, Morphic shall effect a full transfer to AbbVie or its designee (which designee may be an Affiliate or a Third Party manufacturer) of all Morphic Know-How and Joint Know-How relating to the then-current process for the Manufacture of such Technology Transfer Product (the “Manufacturing Process”) and to implement the Manufacturing Process at facilities designated by AbbVie (such transfer and implementation, as more fully described in this Section 5.3, the “Manufacturing Technology Transfer”). To assist with the Manufacturing Technology Transfer, Morphic will make its personnel reasonably available to AbbVie during normal business hours for up to [***] FTE hours with respect to each Included Target (in each case, free of charge to AbbVie) to transfer and implement the Manufacturing Process under this Section 5.3. Thereafter, if requested by AbbVie, Morphic shall continue to perform such obligations; provided, that AbbVie will reimburse Morphic for its full-time equivalent (FTE) costs (for clarity, in excess of [***] FTE hours) and any reasonable and verifiable out-of-pocket costs incurred in providing such assistance. CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.

  • Random Drug Testing All employees covered by this Agreement shall be subject to random drug testing in accordance with Appendix D.

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

Time is Money Join Law Insider Premium to draft better contracts faster.